Clinical trial
Effect of Delivery Route on the Pharmacokinetics of Sufentanil NanoTab® in Healthy Subjects
NCT01639729 is registered in ClinicalTrials.gov with Talphera, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Delivery Route on the Pharmacokinetics of Sufentanil NanoTab® in Healthy Subjects
- Lead sponsor
- Talphera, Inc
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- July 31, 2012
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pharmacokinetics